Literature DB >> 7639751

Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons.

Y Hayashi1, K Matsuyama, K Takagi, H Sugiura, K Yoshikawa.   

Abstract

Necdin is a 325 amino acid residue protein localized to the nuclei of postmitotic neurons, which withdraw permanently from the cell cycle. To examine whether necdin confers the postmitotic phenotype, necdin cDNA was stably transfected into NIH3T3 cells, in which the protein was conditionally expressed using a eukaryotic lac repressor-operator expression system. When the transfectants were induced to express ectopic necdin, cell growth was arrested without appreciable reduction in cell viability. The expressed necdin molecule was localized to the nuclei of the transfectants. These results suggest that necdin is a nuclear factor that governs the permanent arrest of cell growth of postmitotic neurons during development of the nervous systems of vertebrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639751     DOI: 10.1006/bbrc.1995.2132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.

Authors:  Yasushi Kawaguchi; Emi Nishimagi; Akiko Tochimoto; Manabu Kawamoto; Yasuhiro Katsumata; Makoto Soejima; Tokiko Kanno; Naoyuki Kamatani; Masako Hara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

Review 2.  A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.

Authors:  Anna K Lee; Patrick Ryan Potts
Journal:  J Mol Biol       Date:  2017-03-11       Impact factor: 5.469

3.  MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.

Authors:  Sandra Laduron; Rachel Deplus; Sifang Zhou; Olga Kholmanskikh; Danièle Godelaine; Charles De Smet; S Diane Hayward; François Fuks; Thierry Boon; Etienne De Plaen
Journal:  Nucleic Acids Res       Date:  2004-08-17       Impact factor: 16.971

4.  A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression.

Authors:  Bo Hu; Shuhui Wang; Yingze Zhang; Carol A Feghali; Jeffrey R Dingman; Timothy M Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

Review 5.  RNAs of the human chromosome 15q11-q13 imprinted region.

Authors:  Stormy J Chamberlain
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-12-03       Impact factor: 9.957

6.  Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling.

Authors:  Itoshi Nikaido; Chika Saito; Yosuke Mizuno; Makiko Meguro; Hidemasa Bono; Moritoshi Kadomura; Tomohiro Kono; Gerard A Morris; Paul A Lyons; Mitsuo Oshimura; Yoshihide Hayashizaki; Yasushi Okazaki
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

7.  Necdin modulates proliferative cell survival of human cells in response to radiation-induced genotoxic stress.

Authors:  Julie Lafontaine; Guergana Tchakarska; Francis Rodier; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2012-06-12       Impact factor: 4.430

8.  Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

Authors:  Julie Lafontaine; Francis Rodier; Véronique Ouellet; Anne-Marie Mes-Masson
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

9.  Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer.

Authors:  Rachel Haviland; Steven Eschrich; Gregory Bloom; Yihong Ma; Susan Minton; Richard Jove; W Douglas Cress
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

10.  Necdin controls proliferation of white adipocyte progenitor cells.

Authors:  Kazushiro Fujiwara; Koichi Hasegawa; Tsuyoshi Ohkumo; Hiroyuki Miyoshi; Yu-Hua Tseng; Kazuaki Yoshikawa
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.